To The Moon

Joel Hawthorne @louiswinthrop updates us on Friday's activity in $TSLA, $NVDA, $MSFT, $AMD, $AAPL, and today's $VIX and ...TSLA Leads Equity OptionsFrom Youtube: https://www.youtube.com/watch?v=M2ZjbjhBE3A

3.25% dividend yield, strong free cash generation.Oak Street acquisition projected to add $2 billion in EBITDA by 2026.Expects significant volume growth at pharmacies with the introduction of several biosimilar and generic drugs in FY23.Modest FY23 guidance targeting 7% EPS growth despite some sustained headwinds in retail.Investment ThesisCVS Health$CVS Health(CVS)$ is a well-known retail pharmacy chain in the United States that has expanded into healthcare services with Aetna and is targeting Medicare Advantage and Medicaid recipients. In a recent acquisition in the form of Oak Street, CVS will continue this trend.85% of the US population lives within 10 miles of a CVS, and the number of digital customers getting care under CVS Health has increas

Stocks fell Monday, extending losses from Friday after a stronger-than-expected U.S. jobs report rai

Tesla is full of distractions, but don't let the headlines impede your view on how the business is really performing.

Fourth-quarter earnings season continues this week, with close to 90 S&P 500 companies scheduled to

A key point of conflict requires resolutionInvestors can be excused for feeling a sense of confusion

The stock market rally marched higher as the Fed took a slightly more dovish stance, even though it

Apple Inc.'s business came under pressure in the holiday quarter, as the company posted a 5% decline

US jobs report may point to possible soft landing for economyECB, BOE seen raising rates while Brazi

Speculators' love of wagering on Tesla Inc. has propelled Elon Musk's electric-vehicle maker into on